Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2746837rdf:typepubmed:Citationlld:pubmed
pubmed-article:2746837lifeskim:mentionsumls-concept:C0007361lld:lifeskim
pubmed-article:2746837lifeskim:mentionsumls-concept:C0338237lld:lifeskim
pubmed-article:2746837pubmed:issue6lld:pubmed
pubmed-article:2746837pubmed:dateCreated1989-8-23lld:pubmed
pubmed-article:2746837pubmed:abstractTextCat-scratch disease is usually a benign, self-limited disease that causes regional lymphadenopathy. Occasionally, it may present with systemic symptoms and have a prolonged course. To date, antibiotic therapy has not been proved to be of value. We describe three patients with cat-scratch disease who were treated successfully with gentamicin sulfate. Two patients had extensive hepatic involvement, and one patient had regional lymphadenopathy. All three patients responded within 48 hours to intravenous gentamicin. Extensive follow-up has shown no recurrence of symptoms. These cases suggest that gentamicin may be efficacious in shortening the course of cat-scratch disease. Prospective, randomized trials should be performed to confirm these results.lld:pubmed
pubmed-article:2746837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2746837pubmed:languageenglld:pubmed
pubmed-article:2746837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2746837pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2746837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2746837pubmed:statusMEDLINElld:pubmed
pubmed-article:2746837pubmed:monthAuglld:pubmed
pubmed-article:2746837pubmed:issn0098-7484lld:pubmed
pubmed-article:2746837pubmed:authorpubmed-author:GrayG FGFlld:pubmed
pubmed-article:2746837pubmed:authorpubmed-author:WattS MSMlld:pubmed
pubmed-article:2746837pubmed:authorpubmed-author:EdwardsK MKMlld:pubmed
pubmed-article:2746837pubmed:authorpubmed-author:BogueC WCWlld:pubmed
pubmed-article:2746837pubmed:issnTypePrintlld:pubmed
pubmed-article:2746837pubmed:day11lld:pubmed
pubmed-article:2746837pubmed:volume262lld:pubmed
pubmed-article:2746837pubmed:ownerNLMlld:pubmed
pubmed-article:2746837pubmed:authorsCompleteYlld:pubmed
pubmed-article:2746837pubmed:pagination813-6lld:pubmed
pubmed-article:2746837pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:meshHeadingpubmed-meshheading:2746837-...lld:pubmed
pubmed-article:2746837pubmed:year1989lld:pubmed
pubmed-article:2746837pubmed:articleTitleAntibiotic therapy for cat-scratch disease?lld:pubmed
pubmed-article:2746837pubmed:affiliationDepartment of Pediatrics, Vanderbilt University School of Medicine, Children's Hospital of Vanderbilt, Nashville, Tenn 37232.lld:pubmed
pubmed-article:2746837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2746837pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2746837pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2746837lld:pubmed